Inventor profile of:

David A. Ralph

City:

Columbus, Ohio

Country:

United States

Published Applications:

19

Last publication date:

2025-12-18

Top Assignees for applications by David A. Ralph

The entities that hold a legal rights for patent applications filed by inventor Ralph David A.:

Recent patent applications by Ralph David A.

David A. Ralph from Columbus, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-18
US20250382392A1
Chemistry; metallurgy

AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS

#2 | 2025-10-23
US20250325681A1
Human necessities

COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE

#3 | 2024-09-05
US20240294564A1
Chemistry; metallurgy

CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker

#4 | 2024-04-25
US20240132630A1
Chemistry; metallurgy

AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS

#5 | 2024-03-21
US20240092944A1
Chemistry; metallurgy

SYNTHESIS OF UNIFORMLY DEFINED MOLECULAR WEIGHT MANNOSYLATED DEXTRANS AND DERIVATIVES THEREOF

#6 | 2024-03-07
US20240075057A1
Human necessities

Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking

#7 | 2024-01-25
US20240024491A1
Human necessities

MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS

#8 | 2023-11-23
US20230374055A1
Chemistry; metallurgy

CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker

#9 | 2023-09-28
US20230302041A1
Human necessities

Competitive Self-Blocking with Unlabeled Manocept Imaging Agents

#10 | 2023-08-10
US20230248757A1
Human necessities

Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking

#11 | 2023-07-13
US20230218770A1
Human necessities

COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE

#12 | 2023-07-06
US20230210998A1
Human necessities

METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS

#13 | 2023-03-09
US20230070258A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

#14 | 2022-01-13
US20220010036A1
Chemistry; metallurgy

Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof

#15 | 2021-11-04
US20210338827A1
Human necessities

Compounds and methods for diagnosis and treatment of viral infections

#16 | 2021-05-20
US20210145989A1
Human necessities

COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS

#17 | 2021-02-25
US20210052639A1
Human necessities

COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS

#18 | 2020-10-01
US20200306381A1
Human necessities

Compositions and methods for altering macrophage phenotype

#19 | 2020-07-30
US20200237937A1
Human necessities

COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY

InventorID:

2804726 ⎘